Jackson Hole Capital Partners’s Amgen AMGN Stock Holding History

Jackson Hole Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256K	Sell	727 -15	-2%	-$5.35K	0.04%	199
2025 Q4	$243K	Sell	742 -5	-0.7%	-$1.59K	0.04%	196
2025 Q3	$211K	Hold	747	–	–	0.04%	207
2025 Q2	$209K	Hold	747	–	–	0.04%	199
2025 Q1	$233K	Buy	+747	New	+$221K	0.05%	191
2024 Q4	–	Sell	-757	Closed	-$244K	–	275
2024 Q3	$244K	Sell	757 -10	-1%	-$3.27K	0.05%	177
2024 Q2	$240K	Sell	767 -5	-0.6%	-$1.47K	0.05%	184
2024 Q1	$219K	Sell	772 -30	-4%	-$8.78K	0.05%	187
2023 Q4	$231K	Hold	802	–	–	0.06%	181
2023 Q3	$216K	Buy	+802	New	+$200K	0.06%	174
2023 Q2	–	Sell	-842	Closed	-$204K	–	278
2023 Q1	$204K	Hold	842	–	–	0.05%	212
2022 Q4	$221K	Buy	+842	New	+$226K	0.07%	168
2022 Q3	–	Sell	-842	Closed	-$205K	–	262
2022 Q2	$205K	Hold	842	–	–	0.06%	168
2022 Q1	$204K	Buy	+842	New	+$193K	0.06%	172
2020 Q1	–	Sell	-1,187	Closed	-$286K	–	164
2019 Q4	$286K	Hold	1,187	–	–	0.16%	119
2019 Q3	$230K	Buy	+1,187	New	+$228K	0.13%	130

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jackson Hole Capital Partners's AMGN Position: Q1 2026 in Review

Jackson Hole Capital Partners reduced its Amgen (AMGN) stake by 2% in Q1 2026, selling an estimated $5.35K and leaving 727 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #199.

Jackson Hole Capital Partners first reported a position in AMGN in Q3 2019 and has held it in 16 quarters since. The position peaked at $286K in Q4 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Jackson Hole Capital Partners held 727 shares of Amgen worth $256K as of Q1 2026.
Jackson Hole Capital Partners sold 15 Amgen shares in Q1 2026, an estimated $5.35K.
Amgen made up 0.04% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #199 holding.
Jackson Hole Capital Partners first reported a position in Amgen in Q3 2019 and has held it in 16 quarters since.
Jackson Hole Capital Partners's Amgen position peaked at $286K in Q4 2019.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.